Bellicum Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 05/03/2024

Stock Rating
6
Price Target
$0.00
Consensus
-
Upside
8233.33%
Analysts
0
Stock Rating
6
Upside
8233.33%
Analysts
0
Price Target
$0.00
-

Bellicum Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Bellicum Pharmaceuticals's Price has grown, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Bellicum Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Bellicum Pharmaceuticals's Revenue has grown, rising from $500.00k to $1.50M – a growth of 200.00%. In the next year, analysts believe that Revenue will reach $4.17M – an increase of 178.24%. For the next eight years, the forecast is for Revenue to grow by 402.18%.

2023 Rev Forecast
$0.00B
2024 Rev Forecast
$0.01B
2025 Rev Forecast
$0.01B
2026 Rev Forecast
$0.01B
2027 Rev Forecast
$0.01B
2028 Rev Forecast
$0.01B
2029 Rev Forecast
$0.01B
2030 Rev Forecast
$0.01B

Bellicum Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

Bellicum Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

Bellicum Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Bellicum Pharmaceuticals's EBITDA has decreased from $-52.61M to $-26.97M – a 48.74% drop! For the next year, analysts predict that EBITDA will reach $-35.67M – an increase of 32.25%. Over the next eight years, experts believe that Bellicum Pharmaceuticals's EBITDA will grow at a rate of 36.37%.

2023 EBITDA Forecast
$-35666926.00
2024 EBITDA Forecast
$-45455119.39
2025 EBITDA Forecast
$-36988345.82
2026 EBITDA Forecast
$-34150106.75
2027 EBITDA Forecast
$-35250878.52
2028 EBITDA Forecast
$-38550360.75
2029 EBITDA Forecast
$-38117311.70
2030 EBITDA Forecast
$-36778123.48

Bellicum Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Bellicum Pharmaceuticals has seen a decline in its EBIT, from $-54.08M to $-26.98M – a 50.11% decrease. In the next year, analysts predict that EBIT will jump to $-36.20M – up 34.18% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 38.88%.

2023 EBIT Forecast
$-36200864.67
2024 EBIT Forecast
$-46658087.77
2025 EBIT Forecast
$-37718398.16
2026 EBIT Forecast
$-34678295.26
2027 EBIT Forecast
$-35841174.10
2028 EBIT Forecast
$-39333299.16
2029 EBIT Forecast
$-38894077.32
2030 EBIT Forecast
$-37469257.62

Bellicum Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Bellicum Pharmaceuticals's EPS has grown, rising from $-0.81 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00